From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Oops...Hays did it again

By Chris Bailey | Thursday 2 April 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I have had my issues with recruitment sector stocks on this website over the last couple of years, calling investors in PageGroup (PAGE) 'bonkers' or 'overly hopeful' on the basis that 'the problem is that recruitment names are always very geared to the economic cycle' and the assets walk out of the door each evening. Now in a world where we have all learned to use the word 'furloughed' (I guess there are worse American inventions) unless you are providing a bunch of workers for key industries such as food retail and healthcare, it was no huge surprise to see Page's sector peer Hays (HAS) observing that 'the rapidly escalating impact of Covid-19 has driven a very material deceleration in client and candidate activity'…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 08:57:11